| Abstract | At present there is no single medication that targets the metabolic syndrome directly. Bariatric surgery, a treatment option for morbidly obese individuals who fail medical therapy, has been shown to be very effective in treating multiple aspects of the metabolic syndrome. The decrease in insulin resistance is because of significant weight loss and by enhancing secretion of gut hormones such as glucagon-like peptide-1 (GLP-1). |
| Authors | Subhash Kini, Daniel M Herron, Robert T Yanagisawa
(Affiliation: Department of Surgery, Mount Sinai School of Medicine, 5 East 98th Street, 15th floor, New York, NY 10029, USA. subhash.kini at mountsinai.org)
|
| Journal | The Medical clinics of North America
(Med Clin North Am)
Vol. 91
Issue 6
Pg. 1255-71, xi
(Nov 2007)
ISSN: 0025-7125 United States |
| PMID | 17964919
(Publication Type: Journal Article, Review)
|
| Topics |
- Bariatric Surgery
(methods)
- Humans
- Metabolic Syndrome X
(etiology, prevention & control)
- Obesity, Morbid
(complications, surgery)
- Treatment Outcome
|
